Literature DB >> 24062311

Loss of TBK1 induces epithelial-mesenchymal transition in the breast cancer cells by ERα downregulation.

Kyung-Min Yang1, YunShin Jung, Jeong-Mi Lee, WonJoo Kim, Jin Ki Cho, Joon Jeong, Seong-Jin Kim.   

Abstract

Estrogen receptor α (ERα) is the pivotal regulator of proliferation and differentiation in mammary epithelia, where it serves as a crucial prognostic marker and therapeutic target in breast cancer. In this study, we show that the loss of the kinase TANK-binding kinase 1 (TBK1) induces epithelial-mesenchymal transition in ERα-positive breast cancer cells by downregulating ERα expression. TBK1 was overexpressed in ERα-positive breast cancers, where it was associated with distant metastasis-free survival in patients, whereas it was underexpressed in ERα-negative breast cancers. TBK1 silencing decreased expression of epithelial markers and increased expression of mesenchymal markers in ERα-positive breast cancer cells, enhancing tumor growth and lung metastasis in vivo in a manner associated with downregulation of ERα expression. Mechanistically, TBK1 silencing reduced FOXO3A binding to the ERα promoter by inducing the translocation of phosphorylated FOXO3A from the nucleus to the cytoplasm. Thus, our results indicate that the loss of TBK1 expression parallels the loss of ERα expression, in turn helping drive an aggressive breast cancer phenotype. ©2013 AACR

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24062311     DOI: 10.1158/0008-5472.CAN-13-0891

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Axl-mediated activation of TBK1 drives epithelial plasticity in pancreatic cancer.

Authors:  Victoria H Cruz; Emily N Arner; Wenting Du; Alberto E Bremauntz; Rolf A Brekken
Journal:  JCI Insight       Date:  2019-04-02

2.  Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-β1 tumor suppressor activity by binding to Smad3 to interrupt its complex formation with Smad4.

Authors:  Y Park; W Kim; J-M Lee; J Park; J K Cho; K Pang; J Lee; D Kim; S-W Park; K-M Yang; S-J Kim
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

Review 3.  Roles of natural killer cells in immunity to cancer, and applications to immunotherapy.

Authors:  Natalie K Wolf; Djem U Kissiov; David H Raulet
Journal:  Nat Rev Immunol       Date:  2022-05-30       Impact factor: 108.555

4.  Targeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanoma.

Authors:  Ha Linh Vu; Andrew E Aplin
Journal:  Mol Cancer Res       Date:  2014-06-24       Impact factor: 5.852

Review 5.  Targeting TANK-binding kinase 1 (TBK1) in cancer.

Authors:  Or-Yam Revach; Shuming Liu; Russell W Jenkins
Journal:  Expert Opin Ther Targets       Date:  2020-10-05       Impact factor: 6.902

6.  Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.

Authors:  G Xie; A Ji; Q Yuan; Z Jin; Y Yuan; C Ren; Z Guo; Q Yao; K Yang; X Lin; L Chen
Journal:  Br J Cancer       Date:  2014-04-22       Impact factor: 7.640

7.  Breast cancer genes PSMC3IP and EPSTI1 play a role in apoptosis regulation.

Authors:  Eva Capdevila-Busquets; Nahuai Badiola; Rodrigo Arroyo; Víctor Alcalde; Montserrat Soler-López; Patrick Aloy
Journal:  PLoS One       Date:  2015-01-15       Impact factor: 3.240

8.  Targeting HER2(+) breast cancer: the TBK1/IKKε axis.

Authors:  Zhe Jiang; Jeff C Liu; Philip E D Chung; Sean E Egan; Eldad Zacksenhaus
Journal:  Oncoscience       Date:  2014-03-06

9.  Increased TET1 Expression in Inflammatory Microenvironment of Hyperinsulinemia Enhances the Response of Endometrial Cancer to Estrogen by Epigenetic Modulation of GPER.

Authors:  Qiao-Ying Lv; Bing-Ying Xie; Bing-Yi Yang; Cheng-Cheng Ning; Wei-Wei Shan; Chao Gu; Xue-Zhen Luo; Xiao-Jun Chen; Zhen-Bo Zhang; You-Ji Feng
Journal:  J Cancer       Date:  2017-03-12       Impact factor: 4.207

10.  Loss of ERα induces amoeboid-like migration of breast cancer cells by downregulating vinculin.

Authors:  Yuan Gao; Zhaowei Wang; Qiang Hao; Weina Li; Yujin Xu; Juliang Zhang; Wangqian Zhang; Shuning Wang; Shuo Liu; Meng Li; Xiaochang Xue; Wei Zhang; Cun Zhang; Yingqi Zhang
Journal:  Nat Commun       Date:  2017-03-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.